Yes, says a new cost comparison of immediate colposcopy, HPV DNA testing, and conservative management in nearly 3,500 women over a 2-year period. The data are from ALTS?atypical squamous cells of undetermined significance [ASCUS] and low-grade squamous intraepithelial lesion [LSIL] Triage Study.
Yes, says a new cost comparison of immediate colposcopy, HPV DNA testing, and conservative management in nearly 3,500 women over a 2-year period. The data are from ALTS-atypical squamous cells of undetermined significance [ASCUS] and low-grade squamous intraepithelial lesion [LSIL] Triage Study.
Costs of repeat screening or triage tests, office visits, and colposcopy with and without biopsy were included in the model, which was developed by the ALTS Group. Neither nonmedical nor patient-time costs were included, nor does the analysis offer an estimate of cost per year of life or quality-adjusted life-year gained.
What the model did show, however, was that conservative management with repeat cytology once and a high-grade squamous intraepithelial lesion as the threshold for colposcopy was the cheapest-but also least sensitive-strategy. The incremental cost-effectiveness ratio for HPV DNA testing was $3,517 and held true when treatment costs were taken into account.
Kulasingam SL, Kim JJ, Lawrence WF, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006;98:92-100.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More